The findings are significant for the liver research community and others interested in the gut-liver axis. (A) AOAH cleaves the two piggyback fatty acyl chains from the lipid A moiety, inactivating ...

Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, will present new data at IDWeek 2024 focused on ...

Seeking an inflammatory factor causative of the onset of insulin resistance, obesity, and diabetes, we have identified bacterial lipopolysaccharide (LPS) as a triggering factor. We found that ...

DeepCure, a therapeutics company using AI to discover novel drugs for inflammation and immune diseases, today announced it will present data showing its selective BRD4 (BD2) inhibitor DC-9476 is ...

Research explores how excessive sugar consumption can drive systemic inflammation, disrupt the gut and oral microbiomes, and contribute to periodontal inflammation, with implications for global health ...

Plasma lipopolysaccharide (LPS) levels were measured to assess for microbial translocation across mucosal surfaces as a possible contributor to immune activation. Elite controllers demonstrated ...

Named lipopolysaccharide (LPS) and sourced from the Gram-negative bacteria Bacteroides fragilis found in our gastrointestinal (GI) tract, the specific neurotoxin in question is identified as BF-LPS.

Many studies have shown that lipopolysaccharides (LPS) derived from the Prevotella genus are involved in mucosal barrier inflammatory responses, explain the researchers. Prevotella bivia, for example, ...